CONMED Corporation
CNMD Healthcare Medical Devices
CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024.
- Revenue
- −0.70%
- EPS
- +635.0%
- Free cash flow
- −3.65%
- Total debt
- −4.44%
Quarter to September 2026, against a year earlier
Follow CNMD
Alert me
CONMED Corporation (CNMD) P/E ratio
As of 5 November 2026, CONMED Corporation (CNMD) trades at a P/E ratio of 21.7×. Over the past ten years it has ranged from 0.0× (June 2023) to 5,641× (December 2020); the current reading is higher than 22% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 26.9× | 68.54% |
| FY2024 | 16.0× | (69.43%) |
| FY2023 | 52.2× | — |
| FY2022 | 0.0× | — |
| FY2021 | 66.2× | (80.48%) |
| FY2020 | 339× | 209.56% |
| FY2019 | 110× | 149.33% |
| FY2018 | 44.0× | 72.90% |
| FY2017 | 25.4× | (70.07%) |
| FY2016 | 85.0× | 112.21% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 19.1× | 7.91% |
| Jun 2026 | 17.7× | (11.44%) |
| Mar 2026 | 20.0× | (25.70%) |
| Dec 2025 | 26.9× | 17.77% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AORT Artivion, Inc. compare | n/m |
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| ENOV Enovis Corporation compare | n/m |
| TNDM Tandem Diabetes Care, Inc. compare | n/m |
| ALMR Alamar Biosciences, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. compare | 19.1× |
| CNMD CONMED Corporation | 21.7× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)